4
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Relative toxicity of amitriptyline, imipramine, maprotiline and mianserin in acute experiments in rabbits

&
Pages 13-22 | Accepted 17 Sep 1979, Published online: 21 Aug 2008
 

Summary

In conscious rabbits, a slow intravenous infusion of amitriptyline, imipramine, maprotiline or mianserin produced death preceded by convulsions. Amitriptyline produced these effects at the lowest dose, imipramine and maprotiline were intermediate and much higher doses of mianserin were required. Cardiac dysrhythmias in the form of missing QRS complexes were evident in 6 out of 6 animals receiving amitriptyline, 6/6 with maprotiline and 2/6 with imipramine but were not seen in animals receiving mianserin. All four drugs lengthened the P-R interval and widened the QRS complex, though these effects were smallest with mianserin. The convulsive episodes greatly modified cardiovascular parameters and therefore complicated an assessment of cardiovascular toxicity. No convulsive episodes developed in barbiturate-anaesthetized rabbits infused with the antidepressants and heart rate and blood pressure were lowered by all four drugs. The P-R interval was lengthened and the QRS complex increased in width; these effects were greatest with amitriptyline and least with mianserin, which was up to 30-times less effective than amitriptyline in causing cardiovascular disturbances. Dysrhythmias were seen with all four drugs, but only at very high doses with mianserin. In these models it is concluded that the relative cardiovascular toxicity of these antidepressants is in the order amitriptyline > imipramine > maprotiline ≫ mianserin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.